A microfluidic cell-migration assay for the prediction of progression-free survival and recurrence time of patients with glioblastoma

Clinical scores, molecular markers and cellular phenotypes have been used to predict clinical outcomes of patients with glioblastoma. However, their clinical use has been hampered by confounders such as patient co-morbidities, by the tumoral heterogeneity of molecular and cellular markers, and by th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Bin Sheng, Shah, Sagar R., Yankaskas, Christopher L., Bajpai, Vivek K., Wu, Pei-Hsun, Chin, Deborah, Ifemembi, Brent, ReFaey, Karim, Schiapparelli, Paula, Zheng, Xiaobin, Martin, Stuart S., Fan, Chen-Ming, Quiñones-Hinojosa, Alfredo, Konstantopoulos, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855796/
https://www.ncbi.nlm.nih.gov/pubmed/32989283
http://dx.doi.org/10.1038/s41551-020-00621-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855796/
https://www.ncbi.nlm.nih.gov/pubmed/32989283
http://dx.doi.org/10.1038/s41551-020-00621-9

Ejemplares similares